Adalta Capital Management LLC Guardant Health, Inc. Transaction History

Adalta Capital Management LLC

$176 Million
Q2 2025

A detailed history of Adalta Capital Management LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Adalta Capital Management LLC holds 63,363 shares of GH stock, worth $4.28 Million. This represents 1.87% of its overall portfolio holdings.

Number of Shares

63,363

Previous 63,663 0.47%

Holding current value

$4.28 Million

Previous $2.71 Million 21.57%

% of portfolio

1.87%

Previous 1.63%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$37.05 - $52.04 $11,115 - $15,612	-300 Reduced 0.47%	63,363 $3.3 Million
Q1 2025 May 15, 2025	SELL	$31.77 - $49.94 $146,142 - $229,724	-4,600 Reduced 6.74%	63,663 $2.71 Million
Q4 2024 Feb 14, 2025	SELL	$20.2 - $38.11 $54,540 - $102,897	-2,700 Reduced 3.8%	68,263 $2.09 Million
Q3 2024 Nov 14, 2024	SELL	$22.3 - $36.29 $1,338 - $2,177	-60 Reduced 0.08%	70,963 $1.63 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $163,848 - $257,394	9,565 Added 15.56%	71,023 $1.47 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $426,463 - $582,979	-19,762 Reduced 24.33%	61,458 $1.66 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $1,161 - $1,798	45 Added 0.06%	81,220 $2.41 Million
Q2 2023 Aug 23, 2023	SELL	$20.94 - $38.01 $14,658 - $26,607	-700 Reduced 0.85%	81,175 $2.91 Million
Q1 2023 May 16, 2023	SELL	$22.92 - $33.76 $43,318 - $63,806	-1,890 Reduced 2.26%	81,875 $1.92 Million
Q4 2022 Feb 17, 2023	SELL	$25.44 - $59.78 $474,074 - $1.11 Million	-18,635 Reduced 18.2%	83,765 $2.28 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $83,827 - $117,120	-1,920 Reduced 1.84%	102,400 $5.51 Million
Q2 2022 Aug 16, 2022	SELL	$28.82 - $77.35 $72,050 - $193,375	-2,500 Reduced 2.34%	104,320 $4.21 Million
Q1 2022 Jun 15, 2022	SELL	$48.25 - $100.49 $165,980 - $345,685	-3,440 Reduced 3.12%	106,820 $7.08 Million
Q4 2021 Feb 15, 2022	BUY	$88.71 - $120.43 $297,178 - $403,440	3,350 Added 3.13%	110,260 $11 Million
Q3 2021 Nov 16, 2021	SELL	$98.77 - $132.17 $41,285 - $55,247	-418 Reduced 0.39%	106,910 $13.4 Million
Q2 2021 Aug 17, 2021	BUY	$109.77 - $165.68 $20,087 - $30,319	183 Added 0.17%	107,328 $13.3 Million
Q1 2021 May 18, 2021	SELL	$127.04 - $179.1 $165,152 - $232,830	-1,300 Reduced 1.2%	107,145 $16.4 Million
Q4 2020 Feb 17, 2021	SELL	$99.96 - $135.93 $5,997 - $8,155	-60 Reduced 0.06%	108,445 $14 Million
Q3 2020 Nov 17, 2020	BUY	$80.32 - $111.8 $12,047 - $16,770	150 Added 0.14%	108,505 $12.1 Million
Q2 2020 Aug 14, 2020	SELL	$60.49 - $97.5 $166,649 - $268,612	-2,755 Reduced 2.48%	108,355 $8.79 Million
Q1 2020 May 18, 2020	SELL	$59.04 - $88.81 $214,020 - $321,936	-3,625 Reduced 3.16%	111,110 $7.73 Million
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $138,016 - $192,049	2,320 Added 2.06%	114,735 $8.97 Million
Q3 2019 Nov 15, 2019	SELL	$62.59 - $110.3 $57,895 - $102,027	-925 Reduced 0.82%	112,415 $7.18 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $7.25 Million - $10.3 Million	113,340 New	113,340 $9.78 Million

Others Institutions Holding GH

# of Institutions

416

Shares Held

126M

Call Options Held

1.51M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $6.9B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adalta Capital Management LLC with notifications on news.

Account

Adalta Capital Management LLC Guardant Health, Inc. Transaction History